Neuro Startup Makes Debut With $20.9M From Novo, Johnson & Johnson Post author:Sam Post published:February 8, 2018 Post category:BioPharma Syndesi will work to modulate the synaptic vesicle protein SV2A. Source: BioSpace You Might Also Like K2M First-To-Market With 3D-Printed Corpectomy Cage System Following FDA Clearance Of CAPRI Small 3D Static Featuring Lamellar 3D Titanium Technology June 27, 2017 3 Biotechs With Make-or-Break Trial Results, FDA Meetings Coming Soon September 21, 2017 Veloxis Pharma to Shut Down New Jersey Office, Moving All Operations to North Carolina February 28, 2017
K2M First-To-Market With 3D-Printed Corpectomy Cage System Following FDA Clearance Of CAPRI Small 3D Static Featuring Lamellar 3D Titanium Technology June 27, 2017
Veloxis Pharma to Shut Down New Jersey Office, Moving All Operations to North Carolina February 28, 2017
